1. Home
  2. HUN vs ICUI Comparison

HUN vs ICUI Comparison

Compare HUN & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUN
  • ICUI
  • Stock Information
  • Founded
  • HUN 1970
  • ICUI 1984
  • Country
  • HUN United States
  • ICUI United States
  • Employees
  • HUN N/A
  • ICUI N/A
  • Industry
  • HUN Major Chemicals
  • ICUI Medical/Dental Instruments
  • Sector
  • HUN Industrials
  • ICUI Health Care
  • Exchange
  • HUN Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • HUN 4.2B
  • ICUI 3.8B
  • IPO Year
  • HUN 2005
  • ICUI 1992
  • Fundamental
  • Price
  • HUN $16.77
  • ICUI $161.08
  • Analyst Decision
  • HUN Hold
  • ICUI Buy
  • Analyst Count
  • HUN 9
  • ICUI 4
  • Target Price
  • HUN $23.33
  • ICUI $199.67
  • AVG Volume (30 Days)
  • HUN 2.3M
  • ICUI 200.3K
  • Earning Date
  • HUN 02-19-2025
  • ICUI 02-25-2025
  • Dividend Yield
  • HUN 5.95%
  • ICUI N/A
  • EPS Growth
  • HUN N/A
  • ICUI N/A
  • EPS
  • HUN N/A
  • ICUI N/A
  • Revenue
  • HUN $5,987,000,000.00
  • ICUI $2,340,097,000.00
  • Revenue This Year
  • HUN N/A
  • ICUI $4.38
  • Revenue Next Year
  • HUN $4.99
  • ICUI $0.34
  • P/E Ratio
  • HUN N/A
  • ICUI N/A
  • Revenue Growth
  • HUN N/A
  • ICUI 4.04
  • 52 Week Low
  • HUN $15.95
  • ICUI $86.80
  • 52 Week High
  • HUN $27.01
  • ICUI $196.26
  • Technical
  • Relative Strength Index (RSI)
  • HUN 32.41
  • ICUI 51.79
  • Support Level
  • HUN $15.95
  • ICUI $151.92
  • Resistance Level
  • HUN $18.15
  • ICUI $167.49
  • Average True Range (ATR)
  • HUN 0.42
  • ICUI 4.52
  • MACD
  • HUN -0.04
  • ICUI 0.73
  • Stochastic Oscillator
  • HUN 34.53
  • ICUI 61.01

About HUN Huntsman Corporation

Huntsman Corp is a us-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives most of its revenue from the Polyurethanes segment which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: